Skip Navigation


FKH’s Health Datapalooza IV Panel

June 4, 1:30-3:30

Health Datapalooza is the premier national conference on liberating health data to achieve better health outcomes. The event, organized by the Health Data Consortium, showcases in real-time the most innovative tools and services that use Big Data to improve healthcare.

FKH was proud to be a partner and sponsor at Health Datapalooza IV, where FKH Chairman and Health Datapalooza Planning Committee Member Marcia Kean organized a panel on, “Illuminating Disease at the Speed of Light: How Big Data Is Accelerating Biomedical Research and Development.” As the biomedical field explodes with big-data-related R&D activity, four thought leaders demonstrated their online tools to:

  • Turn large volumes of complex data into actionable information.
  • Use high-speed genome profiling for quick molecularly-based diagnoses of “mystery” diseases.
  • Drive a statewide point-of-care quality monitoring program being used by physicians in routine clinical practice, in which data are banked; used to determine important questions for research; and then picked up by a national clinical trials network and transitioned into clinical trials.
  • Enable collection and aggregation of data on multiple sclerosis (MS), drive collaborative efforts to analyze markers of MS origins, and discover new therapeutics.

Panelists included:

  • Amy P. Abernethy, MD
    Director, Center for Learning Healthcare, Duke Clinical Research Institute

Relevant Experience

  • Michael Cantor, M.D., MA, FACP
    Senior Director, Information Strategy and Analytics, World Research and Development, Pfizer

Relevant Experience

  • Robert McBurney, Ph.D.
    CEO, Accelerated Cure Project for Multiple Sclerosis

Relevant Experience

  • Dietrich A. Stephan, Ph.D.
    Founder, President and CEO, and Member of the Board of Directors, SV Bio

Relevant Experience